^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Plenaxis (abarelix)

i
Other names: PPI 149, R 3827
Associations
Trials
Company:
Contura
Drug class:
GnRH antagonist
Associations
Trials
4years
The interaction between MALAT1 target, miR-143-3p, and RALGAPA2 is affected by functional SNP rs3827693 in breast cancer. (PubMed, Hum Cell)
The rs3827693 allele G significantly decreased the breast cancer incidence and augmented the negative correlation between RALGAPA2 and miR-143-3p, presumably through strengthening the interaction between these two transcripts. This study proposed MALAT1 miR-143-3p and miR-143-3p RALGAPA2 axis in breast cancer, whereby the latter can be altered by the clinically functional SNP rs3827693.
Journal
|
MALAT1 (Metastasis associated lung adenocarcinoma transcript 1)
|
Plenaxis (abarelix)